# PSG5

## Overview
The PSG5 gene encodes the protein pregnancy-specific beta-1-glycoprotein 5, which is a member of the carcinoembryonic antigen (CEA) family within the immunoglobulin superfamily. This protein is primarily expressed in the placenta and plays a crucial role in modulating the maternal immune system to promote maternal-fetal tolerance during pregnancy. Structurally, PSG5 contains one immunoglobulin variable-like domain and three immunoglobulin constant-like domains, and it undergoes post-translational modifications such as glycosylation, which are important for its function and stability (Moore2014Pregnancyspecific). Functionally, PSG5 is involved in cell signaling pathways that influence angiogenesis and trophoblast invasion, essential processes for placental development (Jeong2021Depletion). The gene's expression is regulated by transcription factors such as specificity protein 1 (Sp1) and Kruppel-like factors (KLF4 and KLF6), which bind to the PSG5 promoter to activate its transcription (Blanchon2006Activation; Moore2014Pregnancyspecific). Alterations in PSG5 expression have been associated with pregnancy-related complications, highlighting its clinical significance (Camolotto2010Expression).

## Structure
The PSG5 protein is part of the carcinoembryonic antigen (CEA) family within the immunoglobulin superfamily. It typically contains one immunoglobulin variable-like domain (N) and three immunoglobulin constant-like domains (Ig C2-like domains of type A or B), along with a hydrophilic tail (Moore2014Pregnancyspecific). These structural features are shared with other members of the CEA family, contributing to the protein's secondary and tertiary structures. PSG5, like other pregnancy-specific glycoproteins, is known to undergo post-translational modifications such as glycosylation, which can influence its function and stability (Moore2014Pregnancyspecific).

The transcriptional regulation of the PSG5 gene involves several factors, including specificity protein 1 (Sp1) and Kruppel-like factors (KLF4 and KLF6), which bind to specific sites within the PSG5 promoter, activating its expression (Blanchon2006Activation; Moore2014Pregnancyspecific). The PSG5 promoter lacks a TATA-box but contains a GC-box, which is crucial for its activity (Blanchon2006Activation). The regulation of PSG5 is primarily at the transcriptional level, with increased expression during placental development (Blanchon2006Activation).

## Function
PSG5, a member of the pregnancy-specific glycoprotein (PSG) family, plays a significant role in immune modulation during pregnancy, contributing to maternal-fetal tolerance. It is primarily expressed in the placenta, particularly in syncytiotrophoblast cells, and is involved in several molecular processes crucial for placental development and function (Camolotto2010Expression; PANZETTADUTARI2000Transcriptiona).

PSG5 is part of the carcinoembryonic antigen (CEA) family and shares structural similarities with other members of this family. It is involved in cell signaling pathways that influence angiogenesis and trophoblast invasion, processes essential for establishing and maintaining a healthy placenta (Jeong2021Depletion). The protein's activity is linked to the regulation of immune responses, promoting the synthesis of anti-inflammatory cytokines and facilitating a shift from Th1 to Th2-mediated immune responses, which are vital for successful pregnancy outcomes (Camolotto2010Expression).

The transcriptional regulation of PSG5 involves complex interactions between various transcription factors and regulatory elements, including Sp1, KLF4, and RXRa, which are crucial for its expression in placental cells (Camolotto2010Expression; Moore2014Pregnancyspecific). These regulatory mechanisms ensure that PSG5 is expressed at appropriate levels during pregnancy, contributing to its role in placental and fetal development.

## Clinical Significance
Alterations in the expression of the PSG5 gene have been associated with several pregnancy-related complications. Low levels of PSG proteins, including PSG5, in maternal circulation have been linked to conditions such as intrauterine growth retardation and preeclampsia (Camolotto2010Expression). These proteins play a crucial role in modulating the maternal immune system to protect the fetus, and their dysregulation may contribute to adverse pregnancy outcomes (Nores2004Transcriptional).

The transcriptional regulation of PSG5 involves several transcription factors, including specificity protein 1 (Sp1) and Kruppel-like factors (KLF4 and KLF6), which are essential for its expression in the placenta (Blanchon2006Activation; Racca2011KrüppelLike). Disruptions in these regulatory mechanisms could potentially affect PSG5 expression and lead to pregnancy complications. Although the clinical significance of PSG5 gene mutations is not directly addressed in the available literature, the gene's role in placental function and fetal protection suggests that alterations in its expression or regulation could impact pregnancy outcomes (Blanchon2006Activation).

PSG5 is also part of the carcinoembryonic antigen (CEA) family, and changes in its levels have been studied in relation to certain cancers, although specific details on this association are not provided in the context (Moore2014Pregnancyspecific).

## Interactions
The human pregnancy-specific glycoprotein 5 (PSG5) gene is regulated through interactions with several transcription factors, notably specificity protein 1 (Sp1) and Kruppel-like factors (KLF4 and KLF6). Sp1 binds to GT-boxes in the PSG5 promoter region, playing a crucial role in forming specific DNA-protein complexes essential for transcriptional activation. Electrophoretic mobility shift assays (EMSAs) have demonstrated that Sp1 binding is necessary for these complexes, as mutations in the GT-boxes disrupt their formation (Nores2004Transcriptional).

KLF4 and Sp1 synergistically activate the PSG5 promoter, with KLF4 binding to a specific region within the promoter. This interaction is confirmed by chromatin immunoprecipitation (ChIP) assays, which show KLF4's physical interaction with the PSG5 promoter (Blanchon2006Activation). The cooperative interaction between KLF4 and Sp1 is crucial for the regulation of PSG5 expression, highlighting the complex regulatory mechanisms involving these transcription factors (Blanchon2006Activation).

Histone acetylation also plays a significant role in PSG5 expression. The inhibition of histone deacetylases (HDACs) enhances the activity of Sp1 and KLF6, leading to increased transcriptional activity of the PSG5 promoter. This process involves the acetylation of histone H3 and Sp1, promoting a relaxed chromatin state conducive to transcription (Camolotto2013PSG).


## References


[1. (Camolotto2010Expression) S. Camolotto, A. Racca, V. Rena, R. Nores, L.C. Patrito, S. Genti-Raimondi, and G.M. Panzetta-Dutari. Expression and transcriptional regulation of individual pregnancy-specific glycoprotein genes in differentiating trophoblast cells. Placenta, 31(4):312–319, April 2010. URL: http://dx.doi.org/10.1016/j.placenta.2010.01.004, doi:10.1016/j.placenta.2010.01.004. This article has 41 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.placenta.2010.01.004)

[2. (Moore2014Pregnancyspecific) Tom Moore and Gabriela S. Dveksler. Pregnancy-specific glycoproteins: complex gene families regulating maternal-fetal interactions. The International Journal of Developmental Biology, 58(2-3–4):273–280, 2014. URL: http://dx.doi.org/10.1387/ijdb.130329gd, doi:10.1387/ijdb.130329gd. This article has 102 citations.](https://doi.org/10.1387/ijdb.130329gd)

[3. (Nores2004Transcriptional) R. Nores, L. Blanchon, F. López-Dı́az, J.L. Bocco, L.C. Patrito, V. Sapin, and G.M. Panzetta-Dutari. Transcriptional control of the human pregnancy-specific glycoprotein 5 gene is dependent on two gt-boxes recognized by the ubiquitous specificity protein 1 (sp1) transcription factor. Placenta, 25(1):9–19, January 2004. URL: http://dx.doi.org/10.1016/S0143-4004(03)00213-3, doi:10.1016/s0143-4004(03)00213-3. This article has 17 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/S0143-4004(03)00213-3)

[4. (Jeong2021Depletion) Da Som Jeong, Myoung Hee Kim, and Ji‐Yeon Lee. Depletion of ctcf disrupts psg gene expression in the human trophoblast cell line swan 71. FEBS Open Bio, 11(3):804–812, March 2021. URL: http://dx.doi.org/10.1002/2211-5463.13087, doi:10.1002/2211-5463.13087. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/2211-5463.13087)

[5. (Camolotto2013PSG) Soledad A. Camolotto, Ana C. Racca, Magali E. Ridano, Susana Genti-Raimondi, and Graciela M. Panzetta-Dutari. Psg gene expression is up-regulated by lysine acetylation involving histone and nonhistone proteins. PLoS ONE, 8(2):e55992, February 2013. URL: http://dx.doi.org/10.1371/journal.pone.0055992, doi:10.1371/journal.pone.0055992. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0055992)

[6. (Racca2011KrüppelLike) Ana C. Racca, Soledad A. Camolotto, Magali E. Ridano, José L. Bocco, Susana Genti-Raimondi, and Graciela M. Panzetta-Dutari. Krüppel-like factor 6 expression changes during trophoblast syncytialization and transactivates ßhcg and psg placental genes. PLoS ONE, 6(7):e22438, July 2011. URL: http://dx.doi.org/10.1371/journal.pone.0022438, doi:10.1371/journal.pone.0022438. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0022438)

[7. (Blanchon2006Activation) Loïc Blanchon, Rodrigo Nores, Denis Gallot, Geoffroy Marceau, Valérie Borel, Vincent W. Yang, José Luis Bocco, Didier Lémery, Graciela Panzetta-Dutari, and Vincent Sapin. Activation of the human pregnancy-specific glycoprotein psg-5 promoter by klf4 and sp1. Biochemical and Biophysical Research Communications, 343(3):745–753, May 2006. URL: http://dx.doi.org/10.1016/j.bbrc.2006.03.032, doi:10.1016/j.bbrc.2006.03.032. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2006.03.032)

[8. (PANZETTADUTARI2000Transcriptiona) Graciela M. PANZETTA-DUTARI, Nicolás P. KORITSCHONER, José L. BOCCO, Rodrigo NORES, Catherine I. DUMUR, and Luis C. PATRITO. Transcription of genes encoding pregnancy-specific glycoproteins is regulated by negative promoter-selective elements. Biochemical Journal, 350(2):511, September 2000. URL: http://dx.doi.org/10.1042/0264-6021:3500511, doi:10.1042/0264-6021:3500511. This article has 4 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/0264-6021:3500511)